DNA
Ginkgo Bioworks Holdings, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Ginkgo Bioworks has 3 disclosed suppliers and 3 disclosed customers in SEC filings.
Last report2 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
−9.28%
vs ±17.3% implied · ×0.54
shaded = implied · ▲▼ = realized
SentenceThese decreases were partially offset by an increase of $7.6 million in information technology expenses primarily due to a shortfall in contractually committed spending related to our strategic cloud and AI partnership with Google Cloud (see Note 12 of our audited consolidated financial statements included elsewhere in this Annual Report on Form 10-K for further details).
DNA 10-Kaccession 0001628280-26-012346
SentenceThese offerings are supported by easy-to-access fee-for-service programs, including our collaboration with Virica Biotech for AAV manufacturing optimization.
DNA 10-Kaccession 0001628280-26-012346
SentenceThese decreases were partially offset by the recognition of $7.5 million in non-cash revenue from the release of a deferred revenue balance associated with the terminated BiomEdit, Inc. ("BiomEdit") contract in 2025 (see Note 17 of our audited consolidated financial statements included elsewhere in this Annual Report on Form 10-K for further details) and an increase in revenue related to programs with large enterprise customers primarily in the pharmaceutical and biotechnology industries and with the U.S. government (healthcare and defense sectors).
DNA 10-Kaccession 0001628280-26-012346
SentenceWe are currently offering biomonitoring and bioinformatics support services domestically through our partnerships with the CDC and XpresCheck, and internationally.
DNA 10-Kaccession 0001628280-26-012346
SentenceWe are currently offering biomonitoring and bioinformatics support services domestically through our partnerships with the CDC and XpresCheck, and internationally.
DNA 10-Kaccession 0001628280-26-012346
Ginkgo Bioworks Holdings, Inc.
11.25
−1.49 · −11.68%
post 11.12 −1.18%
Linked news
Expected move
Inputs8Q avg ±13.9%·×0.98·fair
straddle ±20.9%
spot 11.21exp Nov 20ATM strike 11ATM straddle 2.75IV 130%